IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy

May 31, 2007 at 4:12 PM Research News
  •   Print
  •   Share
  •   Comments
  •  Text 
IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy
The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio Diagnostics, Inc. (OTC Bulletin Board: CEMI) have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two 'neglected diseases' targeted by IDRI. The tests will be developed by Chembio using Chembio's patented Dual Path immunoassay test platform (DPP(TM)) and will incorporate IDRI's proprietary antigens.

In preliminary studies conducted during the first quarter of 2007, Chembio demonstrated superior analytical sensitivity on certain well-characterized samples from patients with these diseases. These studies resulted in the decision by Chembio and IDRI to enter into two Cooperative Research and Development Agreements to further their joint efforts.

IDRI, which has funding from the National Institutes of Heath and the Bill and Melinda Gates Foundation for the development of vaccines and diagnostics for leishmaniasis, and from the American Leprosy Mission for similar activities in leprosy, actively partners with industrial organizations to achieve its goals of developing products to aid in the control of selected diseases.

Following completion of the prototype tests this year, the parties intend to then seek commitments for procurement of these products for affected populations globally. The leishmania parasite affects millions of people worldwide, while leprosy continues to be an important public health problem, with approximately one million new cases per year. Access to better diagnostic tools will be essential for control of theses diseases.

About Leishmaniasis

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
More News on: Leprosy, Leishmaniasis
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Leishmaniasis
Complete Medindia Resources
News Categories:  
Child Health Center

Research Related News

» New Drug That Only Attacks Cancer Cells Developed » Personality Traits Linked To Longevity in Centenarians
» Lack of Vitamin D in Diet Raises Stroke Risk in Japanese-Americans » Why Bovine TB Continues to Spread Demystified in New Research
» Seaweed Pill May Help Treat Arthritis » P. Aeruginosa Infection Leads to Worse Outcomes and Increased Hospitalizations in COPD Patients
» Hormone Boosts Production of Molecules Which Fight Skin Infection » Protein Discovery Could Lead To New Vaccine for Meningitis
Read More >>